Previously, we reported that DIFs inhibited the Wnt/β-catenin signaling pathway via glycogen synthase kinase-3β (GSK-3β) activation, leading to cell cycle arrest at G0/G1 phase through suppression of cyclin D1 expression in various human tumor cells [20-23]. Here, GSK3B is linked to neoplasm.